Skip to content
Our Company

Holostem is the first biotechnological company entirely devoted to development, manufacture, registration and distribution of Advanced Therapies Medicinal Products (ATMPs) based on cultures of epithelial stem cells both for cell and gene therapy.

READ MORE
MANAGEMENT

Holostem has a highly experienced management team, with a sound know-how derived from a long tenure both in business administration and in academic research, successfully applied since many years in translational medicine.

READ MORE
PUBLICATIONS

Our scientist are author of over 150 peer-reviewed publications in major international journals.

Publications
Back To Top